腾讯网10 小时
Nature Biotechnology | 细胞治疗新突破：SEED-Selection带来更高效的T细胞筛选
引言近年来，基因编辑技术在免疫治疗和细胞治疗领域取得了飞跃性进展，尤其是在T细胞工程化改造（T cell engineering）方面。T细胞的基因编辑对于CAR-T疗法、异基因T细胞治疗（Allogeneic T cell ...
Medscape7 小时
Promise for CAR T-Cell Therapies in Solid Tumors?
CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...
AFP2 小时
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance ...
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary ...
No evidence that CAR T cell therapy causes secondary cancers, large study shows
Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...
technologynetworks6 天
Study Finds No Evidence CAR T-Cell Therapy Causes Secondary Cancers
A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.
GEN8 天
Making Strides Toward Off-the-Shelf CAR T Cell Therapy for Cancer
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
Medical Xpress on MSN10 天
Study Paves Way for Off-the-Shelf Cancer CAR T-Cell Therapy
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
Gene modification can encourage T cell growth, improving cancer treatment's success rate
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
rheumatologyadvisor3 天
Gamma Delta CAR T-Cell Therapy Fast Tracked for SLE With Extrarenal Involvement
The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.
CAR T-Cell Therapy Market to Reach US$ 22.2 Billion By 2032 | Astute Analytica
CAR T-Cell therapy market growth is propelled by revolutionary results in treating certain blood cancers.New Delhi, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The global CAR T-cell therapy market valuation is ...